Clene Inc. — Director's Dealing 2021

Jan 4, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Clene Inc. (CLNN)
CIK: 0001822791
Period of Report: 2020-12-30

Reporting Person: Jacobovitz Shalom (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	54207.00	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Incentive Stock Option (right to buy)	$0.7918		Common Stock (395933.00)		Direct

Footnotes

F1: Awarded under the Clene Nanomedicine, Inc. 2014 Stock Plan on April 24, 2018 and currently exercisable. The options expire 10 years from the date of the grant.